Guiding management of therapy in prostate cancer: time to switch from conventional imaging to PSMA PET?

Radiolabelled small molecules for imaging prostate cancer have rapidly emerged over the last few years with gallium-68-labelled prostate-specific-membrane-antigen-11 ((68)Ga-PSMA11), the most widely used. However, the current evidence-based guidelines for management of prostate cancer were establish...

Descripción completa

Detalles Bibliográficos
Autores principales: Alipour, Ramin, Azad, Arun, Hofman, Michael S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Challenging Dogma: New Evidence to Guide Practice in Urologic Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755643/
https://www.ncbi.nlm.nih.gov/pubmed/31565073
http://dx.doi.org/10.1177/1758835919876828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755643/
https://www.ncbi.nlm.nih.gov/pubmed/31565073
http://dx.doi.org/10.1177/1758835919876828

Ejemplares similares